These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33511950)

  • 1. Non-glycemic Adverse Effects of Insulin.
    Guarneri AM; Hoffman RP
    Curr Diabetes Rev; 2022; 18(2):e012821190877. PubMed ID: 33511950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study.
    Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Insulin-Induced Lipodystrophy on Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Tsadik AG; Atey TM; Nedi T; Fantahun B; Feyissa M
    J Diabetes Res; 2018; 2018():4910962. PubMed ID: 30116742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus.
    Bertuzzi F; Meneghini E; Bruschi E; Luzi L; Nichelatti M; Epis O
    J Endocrinol Invest; 2017 Oct; 40(10):1107-1113. PubMed ID: 28452000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society.
    Tian T; Aaron RE; Huang J; Yeung AM; Svensson J; Gentile S; Forbes A; Heinemann L; Seley JJ; Kerr D; Klonoff DC
    J Diabetes Sci Technol; 2023 Nov; 17(6):1711-1721. PubMed ID: 37555266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
    Luo D; Shi Y; Zhu M; Wang H; Yan D; Yu J; Ji J; Liu X; Fan B; Xu Y; Zhang M; He W; Xu J; Yang T
    J Diabetes Complications; 2021 Mar; 35(3):107806. PubMed ID: 33280982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: A prospective cohort study in China.
    Wang W; Huang R; Chen Y; Tu M
    Medicine (Baltimore); 2021 Jul; 100(29):e26743. PubMed ID: 34398053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early rapid onset lipohypertrophy in a patient with type 1 diabetes mellitus.
    Bird P; Fowler I; Boyle MJ
    Aust N Z J Med; 1998 Aug; 28(4):467-8. PubMed ID: 9777118
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks.
    Huang J; Yeung AM; Kerr D; Gentile S; Heinemann L; Al-Sofiani ME; Joseph JI; Seley JJ; Klonoff DC
    Endocr Pract; 2023 Aug; 29(8):670-677. PubMed ID: 37098370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
    Hernar I; Haltbakk J; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipohypertrophy Effect on Glycemic Profile in an Adult With Type 1 Diabetes Using Scanned Continuous Glucose Monitoring.
    Oriot P; Hermans MP
    J Diabetes Sci Technol; 2020 Mar; 14(2):500-501. PubMed ID: 31847568
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Errors in insulin treatment management and risk of lipohypertrophy.
    Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
    Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-induced lipodystrophy and interest of insulin injection ports.
    Ben Abdelkrim A; Fathallah N; Omri M; Hasni Y; Khaldi S; Kacem M; Chaieb M; Ben Salem C; Maaroufi A; Ach K
    Therapie; 2019 Dec; 74(6):680-682. PubMed ID: 31088690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.